Sonova Holding AG (OTCMKTS:SONVY - Get Free Report) has been given an average recommendation of "Reduce" by the six brokerages that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating and four have assigned a hold rating to the company.
Several equities research analysts have weighed in on SONVY shares. HSBC cut Sonova from a "buy" rating to a "hold" rating in a research note on Wednesday, May 21st. Hsbc Global Res cut Sonova from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, May 21st.
View Our Latest Report on Sonova
Sonova Trading Down 2.3%
OTCMKTS SONVY traded down $1.46 on Friday, hitting $62.18. 8,763 shares of the company's stock were exchanged, compared to its average volume of 20,004. The stock has a 50-day moving average of $60.31 and a 200-day moving average of $64.36. The company has a quick ratio of 0.82, a current ratio of 1.21 and a debt-to-equity ratio of 0.61. Sonova has a 52 week low of $52.83 and a 52 week high of $77.56.
About Sonova
(
Get Free ReportSonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Featured Articles

Before you consider SONOVA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SONOVA wasn't on the list.
While SONOVA currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.